Medivation Competitors and Similar CompaniesClear all
CureVac's competitors and similar companies include Northwest Biotherapeutics and Candel Therapeutics.
 Northwest Biotherapeutics Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer. |  Candel Therapeutics Candel Therapeutics (formerly known as Advantagene) is a biopharmaceutical company developing cancer immunotherapies. | ||
Founding Date | Founding Date 2000 | Founding Date 1998 | Founding Date 1999 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US | Locations Bethesda, US HQ | Locations Needham, US HQ |
Employees | Employees 82517% decrease | Employees 1721% increase | Employees 50 |
Valuation ($) | Valuation ($) 648.3 m | Valuation ($) 349.5 m | Valuation ($) 176.8 m |
Financial | |||
Revenue (est.) | Revenue (est.) €535.2m (FY, 2024) | Revenue (est.) $1.4m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income €162.2m (FY, 2024) | Net income ($60.2m) (FY, 2025) | Net income ($38.2m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 1.1b | Total funding raised $ 135.9m | Total funding raised $ 64.6m |
For sources of this data, please see the company profile
View Company Profiles
Northwest Biotherapeutics
HQ
Bethesda, US
Employees
17↑ 21% increase
Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.
View companyCandel Therapeutics
HQ
Needham, US
Employees
50
Candel Therapeutics (formerly known as Advantagene) is a biopharmaceutical company developing cancer immunotherapies.
View company